Two-fractionated stereotactic magnetic resonance-guided adaptive radiation therapy for patients with prostate cancer (SMART PRO trial): protocol for a confirmatory clinical trial
Two-fractionated stereotactic magnetic resonance-guided adaptive radiation therapy for patients with prostate cancer (SMART PRO trial): protocol for a confirmatory clinical trial
Keiichi Jingu, Hiroyuki Okamoto, Takashi Uno, Takashi Kawaguchi et al.
Citations
1 citations
Journal
BMJ Open
Topics
Prostate Cancer Diagnosis and Treatment
Field-Weighted Citation Impact (FWCI)
0.42
article
Two-fractionated stereotactic magnetic resonance-guided adaptive radiation therapy for patients with prostate cancer (SMART PRO trial): protocol for a confirmatory clinical trial
Tokyo University of Pharmacy and Life Sciences (JP), Chiba University (JP), Tohoku University (JP), Osaka City University (JP), National Cancer Center (US), Saiseikai Kumamoto Hospital (JP), National Cancer Center Hospital East (JP), Saitama Medical University (JP), The University of Osaka (JP)
Funders
Japan Agency for Medical Research and Development, Ministry of Education, Science and Technology